Home
Nonclinical Services
Nonclinical Services
Safety Assessment

PCC nomination supporting studies

IND-enabling studies

NDA/BLA-enabling studies

Efficacy Studies

Exploration of the MOA

PD Evaluation (in vitro/in vivo)

DMPK Studies

ADME studies of chemical drugs

PK studies of biologics

Clinical Services
Clinical Services
POC Clinical Trials

Clinical development strategy

Phase I/II studies

Study design and operations

Medical monitoring

Pharmacovigilance

Data management

Pivotal Clinical Trials

Phase II/III studies

Study design and operations

Medical monitoring

Pharmacovigilance

Reporting and regulatory submission

Supporting clinical services

Investor
Investor
AnnouncementCorporate GovernancePromotional MaterialsInvestor Contact
TriApex Vision
Building a CRO "bioeconomy" industry ecosystem that meets international standards and is domestically first-class
About us
About us
TriApex Profile Social ResponsibilityJoin us
鼎泰愿景
Dedicated to scientific assessment, enabling transformation of innovation, and improving quality of life
Global
En Cn
×
Location： Home Disease-Oriented R&D Ophthalmology In vivo Ocular Disease Models
Induced Corneal Neovascularization

Introduction

The corneal neovascularization can be induced in various animals by corneal suture or chemicals. This model can be used early model for efficacy test of anti-neovascularization drugs.

Disease-Oriented R&D
Ophthalmology
In vivo Ocular Disease Models
Ocular Routes of Administration
Clinical Ophthalmology Examinations
Bioanalysis of Eye Tissues
Ophthalmology Pathology Evaluation
Clinical Service
CNS
Disease Models
Drug Safety Assessment
Clinical Research Services
Project Experience
Metabolic Disease
Disease Models
Service Capacity
Clinical Research Services
Project Experience
Innovation
iPSCs & Organoids Evaluation Department
Cell Biology & Immunology Evaluation Department
An innovative CRO dedicated to providing disease-oriented one-stop solutions to enable the R&D for global pharmaceutical enterprises and research institutions.
Nonclinical Services

Safety Assessment

Efficacy Studies

DMPK Studies

Clinical Services

POC Clinical Trials

Pivotal Clinical Trials

About us

TriApex Profile

Social Responsibility

Join us

Tel：+86 (025) 5819-6588

Email：bd@tri-apex.com | marketing@tri-apex.com

Address：No. 9 Xinglong Road, Jiangbei New Area, Nanjing, China

Official WeChat account
Copyright©TriApex Laboratories Co., Ltd.   苏ICP备18053553号-3   苏公网安备32011202001081